Treatment   |  Growth   |  Strategy
 LIVE ONLINE 16 November 2020
Bio Integrates Speakers 2020
STEVE BATES
Chief Executive Officer
UK Bioindustry Association
SEAN MARETT
Chief Business & Commercial Officer
BioNTech
THEO HAROLD
Chief Executive Officer
Crescendo Biologics
CLIVE DIX
Chief Executive Officer
C4X Discovery
STEVE HARRIS
Chairman
Synchrony Pharma
KARIN SCHMITT
Chief Business Officer
Mogrify
IAN CAMPBELL
Interim Executive Chair
Innovate UK
PRIYA MANDE
Chief Operating Officer
PsiOxus Therapeutics
TOBY REID
Chief Executive Officer
BioCity Group
ZUZANNA BRZOSKO
Co-founder and Chief Executive Officer
Sixfold Bioscience
JOHN DAWSON
Chief Executive Officer
Oxford Biomedica
RICHARD WEAVER
Founder and Managing Director
Xenogesis
KEITH THOMPSON
Chair, Pharma Advisory Board
Deep Science Ventures
ZAHID LATIF
Innovation Specialist, Life Sciences Organisation, International Trade & Investment Group
Department for International Trade
KEVIN COX
Chair
ValiRx
JASON MELLAD
Chief Executive Officer
Start Codon
GLENN CROCKER
Head of Life Sciences, JLL & Chairman, BioCity Group
JLL & BioCity Group
SALLY WATERMAN
Chief Operating Officer, Medherant
Sixfold Bioscience
CHRIS TORRANCE
Chief Executive Officer
PhoreMost
BARBARA DOMAYNE-HAYMAN
Entrepreneur-in-residence
Francis Crick Institute
MICHAEL BENNETT
Director of Business Development
Cell and Gene Therapy Catapult
JASON LACOMBE
Chief Executive Officer
Veratrak
DARREN CLARK
Chief Executive
Medilink Midlands
MAUREEN COLEMAN
Chair
CN BioInnovations
ALLAN MARCHINGTON
Managing Partner & Senior Advisor
Bridge Valley Ventures & Apposite Capital
TONY JONES
Chief Executive Officer
One Nucleus
GEOFF DAVISON
Chief Executive Officer
Bionow
SALLY ANN FORSYTH
Chief Executive Officer
Stevenage Bioscience Catalyst
GERALD LAW
Chief Executive
Innovation DB
THOMAS OGORKA
Chief Executive Officer
Orphan Reach
MAIREADH PEDERSEN
Chief Executive Officer
QuayPharma
JESÚS ZURDO
Global Head Bioproduction
Horizon Discovery
EMMA BANKS
Managing Director
ramarketing
RICHARD BUTT
Chief Executive Officer
Apollo Therapeutics
JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly and Company
JAMES SPICER
Professor of Experimental Cancer Medicine
King’s College London
MARK LEES
Vice President – Corporate Strategy and Operations
Mestag Therapeutics
NICOLA HERON
Head of Collaborative R&D
Medicines Discovery Catapult
DANIEL SMITH
Chief Scientific Officer & Industry Professor, School of Life Science
Cobra Biologics & University of Warwick
CLAIRE THOMPSON
Chief Executive Officer
Agility Life Sciences
CHRISTIAN JONES
Chief Commercial Officer
Nanoform
TERESA LAVOIE
Principal
Fish & Richardson
JOANNA GOULD
Chief Executive Officer and Co-founder
VisusNano
MAYER SCHREIBER
Chief Executive Officer
Discovery Park
JO CRAIG
Senior Vice President CMC
NeRRe Therapeutics
ELISABETH GOODMAN
Owner and Principal Consultant
RiverRhee Consulting
FAZ CHOWDHURY
Chairman and Chief Executive Officer
Nemaura
PAUL STOTT
Chief Executive Officer
Seda Pharmaceutical Development Services
EDDY LITTLER
Chief Operating Officer
ReViral
NICK JOHNSON
Chief Strategy Officer
Cell and Gene Therapy Catapult
STEPHEN TOOKER
Vice President, Commercial Packaging – Europe
PCI Pharma Services
DEREK JONES
Chief Executive Officer
Seda Pharmaceutical Development Services
KATH MACKAY
Managing Director
Bruntwood SciTech – Alderley Park
JOE DE SOUSA
Senior Leader, Non-Exec Director and Independent Consultant
Melhor Consulting
NEIL HAWKINS
Partner & Director | Professor of Health Technology Assessment
Visible Analytics | University of Glasgow
ROS HANNEN
Chief Executive Officer
Keratify
FLIC GABBAY
Managing Partner
tranScrip
BEVERLEY CARR
Chief Business Officer
Achilles
DECLAN JONES
Vice President and Head of External Innovation (EI) and Scientific Licensing
Ferring Research Institute
DETLEF BEHRENS
Managing Director
Bay Pharma
EUAN CAMERON
Chief Executive Officer & Founder
COHESION Medical
ALLAN JORDAN
Director of Oncology Drug Discovery
Sygnature Discovery
EDDIE BLAIR
Chairman
Virokine Therapeutics
LAURA ITZHAKI
Chief Scientific Officer
PolyProx Therapeutics
MIKE SNOWDEN
Senior Vice President Discovery Sciences, Biopharmaceuticals R&D
AstraZeneca
CLARE TERLOUW
Head of Ventures
LifeArc
CHARLES STEWARD
Patient Advocacy and Engagement Lead
Congenica
JONATHAN APPLEBY
Chief Scientific Officer
Cell and Gene Therapy Catapult (CGT Catapult)
DOUG CUFF
Vice President of U.K. Real Estate
IQHQ
KARL KEEGAN
Chief Executive Officer, Non-Executive Director
Hox Therapeutics Ltd, Nuformix Plc and Novai Ltd.
CHRISTOPHE MULLER
Global Head, Business Development
Evotec (UK) Ltd
RICHARD HEBDON
Head of Health & Medicine, Ageing Society, Health & Nutrition Sector
Innovate UK
TIM LUKER
Vice President Emerging Technology and Innovation
Eli Lilly
HELEN BARKER
Head of Pharmaceutical Development
Reneo Pharma
ROGER KILBURN
Chief Executive Officer
Arcinova
NATALIA NOVAC
Senior Director, Emerging Technology & Innovation, Corporate Business Development
Eli Lilly
SHARON BROWNLOW
Chief Business Officer
Cell & Gene Therapy Catapult
JASON CAMERON
Senior Vice President, Global Technical Operations
Amicus Therapeutics
NOOR SHAKER
Chief Executive Officer
GlamorousAI
OLIVIA CHAMPION
Founder and Chief Executive Officer
BioSystems Technology
LUCY FOLEY
Director of Biologics
CPI
JAY STELLA
Chief Business Officer
Sai Life Sciences
SAMUEL NEILL
Business Development Manager
CPI
JONAS MOLLER
Chief Executive Officer
Albumedix
ANNA PERDRIX ROSELL
Co-founder and Managing Director
Sixfold Bioscience
MICHAEL HUNT
Chief Financial Officer
ReNeuron Group plc
TOM MANDER
Chief Operating Officer
Domainex
JAN THIRKETTLE
Chief Development Officer
Freeline
CAMPBELL BUNCE
Chief Scientific Officer
Abzena
KRISHNA KANUMURI
Managing Director & Chief Executive Officer
Sai Life Sciences
ELIOT FORSTER
Chief Executive Officer
F-star
WILL BROOKS
Investment Director
Downing
Valued silver sponsorsÂ
Treatment   |  Growth   |  Strategy